Greg has over 25 years of experience guiding biotech and pharma projects to worldwide approval and market launch. He has filed clinical trial applications and marketing applications in every major worldwide market, championing efficient and effective paths to improve human health. Greg has led regulatory, quality, and clinical teams for ArQule and was the Alliance leader for key strategic collaborations with Roche and Daiichi. He previously was a partner and president of Halloran Consulting Group and held leadership roles with Antigenics and Genzyme. His development experience spans metabolic disease, oncology, cardiovascular, and rare genetic diseases.
Greg has a B.S. in Biology from the University of North Carolina at Chapel Hill and a professional change management certification from Colorado State University.